NCT06048133 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT06048133
Title	Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers
Recruitment	Recruiting
Gender
Phase	Phase II
Variant Requirements	No
Sponsors	Nataliya Uboha
Indications	biliary tract cancer
Therapies	AB680 + Cisplatin + Gemcitabine + Zimberelimab
Age Groups:	adult \| senior
Covered Countries	USA

Filter rows:

Showing 1 to 4 of 4 entries

Facility	Status	City	State	Zip	Country	Details
Indiana University Melvin and Bren Simon Comprehensive Cancer Center	RECRUITING	Indianapolis	Indiana	46202	United States	Details
Rutgers Cancer Institute of New Jersey	RECRUITING	New Brunswick	New Jersey	08903	United States	Details
University of Michigan Health System	RECRUITING	Ann Arbor	Michigan	48109	United States	Details
University of Wisconsin	RECRUITING	Madison	Wisconsin	53705	United States	Details

Showing 1 to 4 of 4 entries

Filter rows:

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT06048133Clinical Trial Detail